Curation MRUPAV PLIN4

Gene PLIN4
Disease MRUPAV
Inheritance AD
Score

7.5 + 3.5 = 11 / 18

Genetic + experimental = total
Classification
0
18
Refuted
Moderate
Definitive
Last Updated 08/11/2025
Pubs Reviewed 6
Publication Span 5.17 years
Publication Interval 5.17 years
Curator(s) Macayla Weiner, Laurel Hiatt
Description

Autosomal dominant MRUPAV/PLIN4-related vacuolar myopathy is caused by heterozygous coding 99-bp repeat expansions in PLIN4 within the exon encoding the amphipathic perilipin-4 domain. Reported affected families and sporadic cases show adult-onset distal and/or proximal myopathy, rimmed/autophagic vacuoles, and subsarcolemmal or cytoplasmic PLIN4/perilipin-4 aggregates that co-localize with p62/SQSTM1, FK2, NBR1, and other aggrephagy markers. Expanded alleles have been detected by PCR and long-read sequencing, with supporting linkage/segregation, absence from unaffected relatives or controls, and patient muscle studies showing expanded PLIN4 protein and aggrephagy activation.

Genetic evidence

Total: 7.5

Category
Type
Citation
Score
Details
Singular Evidence
Probands
6

PMID:36151849 reported one autosomal-dominant family and one sporadic adult-onset PLIN4-myopathy case with a heterozygous coding 99-bp PLIN4 repeat expansion and characteristic p62/perilipin-4-positive vacuolar pathology. PMID:32451610 reported a multigenerational 19p13.3-linked kindred with a PLIN4 40×99-bp expansion, absent from unaffected relatives/controls, and rimmed ubiquitin-positive autophagic vacuoles.

Collective Evidence
Computational
0

PMID:40693562 used WES coverage and RNA-seq review as part of the workup: increased PLIN4 exon coverage suggested an expanded allele, while RNA-seq showed normal PLIN4 expression and no splicing effect; ONT sequencing confirmed the expansion. PMID:39102614 is a clinical cohort/prognostic study and does not provide TR-specific computational pathogenicity evidence.

Collective Evidence
Segregation
1.5

PMID:36151849 reported linkage in the PLIN4-related family to a 3.39 Mb 19p13.3 candidate interval (chr19:2635061–6033965) with maximum LOD 3.0408; PCR showed the expanded PLIN4 band in affected individuals and only the wild-type band in unaffected relatives.

Experimental evidence

Total: 3.5

Category
Type
Citation
Score
Details
Function
Biochemical function
0.5

PMID:40693562 showed increased PLIN4 at the sarcolemma/vacuoles in patient muscle and discussed that PLIN4 repeat expansion may alter lipid-droplet membrane-binding specificity, promoting abnormal sarcolemmal targeting and aggregation of perilipin-4.

Function
Protein interaction
1.5

PMID:35499779 showed patient muscle perilipin-4 co-localized with FK2, p62/SQSTM1, NBR1, and LC3B in vacuoles/subsarcolemma, consistent with aggrephagy-related aggregation. PMID:40693562 similarly showed PLIN4 co-localization with p62 and NBR1 at sarcolemma/vacuoles and detected a higher-molecular-weight PLIN4 band from the expanded allele by western blot.

Function
Regulatory impact
0.5

PMID:40693562 reported patient muscle RNA-seq with normal PLIN4 mRNA expression and no observed PLIN4 splicing effect. Western blot revealed increased PLIN4 protein expression in patients compared with controls.

Functional Alteration
Patient cells
1

PMID:37145156 reported patient muscle biopsy findings in affected PLIN4 expansion carriers, including rimmed vacuoles and PLIN4, FK2, p62/SQSTM1, and NBR1 positivity/accumulation in muscle fibers; biopsies were abnormal even in some minimally symptomatic carriers.

Maximum score caps apply at evidence type, category, and supercategory levels, so section totals may be lower than the raw sum of row scores.